Johnson & Johnson shared some very promising news about its single-dose COVID-19 vaccine announcing that it prevents 85 percent of severe cases of the disease and "72% Effective in the US and 66% effective overall at preventing moderate to severe COVID-19, 28 Days after vaccination."
